Supply of Zinc Oxide Ointment (Topical Skin Protectant)

The contract requires the manufacture and supply of four units of 20 percent zinc oxide ointment, each packaged in one-ounce collapsible tubes, as a commercial off-the-shelf pharmaceutical product designated as USP for topical skin protection. The product must meet established USP standards for purity, potency, and consistency, and be suitable for direct use in medical or clinical settings without customization. The ointment is intended for protective applications on skin, likely for wound care, irritation prevention, or barrier maintenance, with specific packaging requirements ensuring ease of use, sterility, and stability. The solicitation is issued as a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance designated for Richmond, Virginia, zip code 23237-0000. The request was posted on July 28, 2026, and responses are due by August 3, 2026, indicating a short turnaround time typical of urgent medical supply needs. The NAICS code 325412 identifies the industry as pharmaceutical and medicine manufacturing, confirming the requirement for qualified, regulated production capabilities. Interested parties must comply with COTS standards and ensure full adherence to pharmaceutical quality controls throughout production and packaging, with delivery aligned to the specified location under the terms of the subcontract agreement.